全球植入式心臟監視器市場：市場規模、佔有率和趨勢分析（2025-2032 年）

全球植入式心臟監測器市場報告

預計到2025年，全球植入式心臟監測器市場規模將超過13.2億美元，到2032年將以4.6%的複合年成長率成長，達到近18.1億美元。這一成長是由對長期心率監測和早期檢測心律不整的需求不斷成長所驅動的。

本報告沿用範例的結構和調查方法，並針對植入式心臟監測器市場及其具體應用案例進行了客製化。報告詳細分析了全球不同地區的銷售量、平均售價、手術例數和競爭格局。

在人口老化以及肥胖、糖尿病和其他代謝危險因子日益普遍的背景下，心血管疾病在全球範圍內持續上升。全球60歲及以上人口已超過12億，預計到2030年代初將接近15億，因此，需要心律不整監測的患者群體正在不斷擴大。

市場成長的主要驅動力之一是將人工智慧 (AI) 整合到植入式心臟監視器中。美敦力公司的 AccuRhythm 和雅培公司的 Assert-IQ 等技術透過減少假陽性結果，同時保持對臨床重要事件的敏感性，提高了診斷準確性，從而增強了醫生的信心，並推動了更廣泛的應用。

市場概覽

全球植入式心臟監測器市場由用於連續、長期監測心率的植入式設備所組成。這些設備通常用於那些不頻繁或原因不明的心律不整患者，對於這類患者，傳統的外部監測方法不足以滿足需求。

植入式心臟監測器在診斷諸如房顫、暈厥和不明原因中風等疾病方面發揮著至關重要的作用。由於它們可以進行長時間的連續監測，臨床醫生能夠捕捉到一些原本可能被忽略的間歇性事件。

該市場與心血管疾病的發展趨勢密切相關。隨著老齡化成長和合併症增多，心律不整的盛行率也隨之上升，促使長期監測解決方案的需求持續增加。植入式監測器正擴大被納入標準診斷流程，尤其是在有中風或突發心臟事件風險的患者中。

技術進步正在重塑市場格局。設備變得更小巧、更易於植入，更容易與遠端監測平台整合。人工智慧演算法的引入提高了診斷準確性，減輕了臨床醫生的工作量，鞏固了植入式心臟監測器作為現代心臟護理重要工具的地位。

市場促進因素

植入式心臟監測器市場的發展動力源自於降低心血管疾病死亡率的需求。鑑於心血管疾病仍是全球首要死因，早期發現心律不整並啟動適當治療具有重要的臨床意義。植入式監測器為識別高風險患者中具有臨床意義的事件提供了一種可靠的方法。

心律不整檢測和治療技術的進步也推動了市場成長。隨著複雜心律不整治療方法的改進，精準診斷的價值日益凸顯。植入式監測器能夠檢測出罕見且無症狀的心律不整，否則這些心律不整將無法被診斷出來，因此這類設備的使用量不斷增加。

人工智慧 (AI) 是最重要的技術驅動力。 AI 驅動的偵測演算法在維持高靈敏度的同時，還能減少誤報。這提高了工作流程效率，增強了醫生對設備數據的信心，並加速了其在臨床環境中的廣泛應用。

市場限制

植入式心臟監測器市場的主要阻礙因素是植入手術的高成本。截至2025年，植入手術的總費用通常在10,000美元至15,000美元之間。這意味著即使在擁有醫療保險的已開發國家，手術費用也超出了許多患者的預算。

成本限制也影響新興市場的普及，因為這些市場的醫保報銷機制可能無法充分支援植入式監測器的使用。因此，植入式監測器的使用仍集中在高所得地區和專業醫療中心。

另一個限制因素是需要明確的臨床證據。雖然植入式監測器能夠提供有價值的診斷數據，但其使用必須與成本相權衡。在某些情況下，醫生可能會在進行植入手術前選擇成本較低的體外監測方法。

市場覆蓋範圍和數據範圍

定量研究範圍

市場規模、市佔率、市場預測、成長率、銷售量、平均售價。

定性研究範圍

市場促進因素和限制因素、成長趨勢、競爭分析、併購、公司簡介和產品系列。

目標期

基準年：2025 年，歷史資料截至 2022 年，預測至 2032 年。

包含的資料類型

銷售量、平均售價、治療次數、市場規模和成長趨勢。

目標市場及區隔

本報告涵蓋全球植入式心臟監視器市場。

該市場作為一個單一細分市場進行分析，反映了植入式心臟監測技術在整體臨床應用中的標準化性質。

所有數據按銷售量、平均售價和市場價值分類，並包括 2032 年的預測。

競爭分析

至2025年，美敦力將以其LINQ II和Reveal LINQ系統引領全球植入式心臟監護市場。 LINQ II平台憑藉其先進的AI驅動心律不整偵測和增強的遠距監護功能，鞏固了美敦力的市場領導地位。 Reveal LINQ系統因其微創設計和成熟的臨床性能，在長期監護應用中持續廣泛應用。

雅培擁有第二大市場佔有率，其產品系列包括Confirm Rx、Jot Dx和Assert-IQ等設備。這些系統提供行動數據傳輸功能和簡化的遠端監控，從而支援高效的患者管理。雅培整合的基於人工智慧的檢測演算法提高了診斷準確性，並增強了公司的競爭優勢。

波士頓科學公司憑藉其LUX-Dx植入式心臟監視器佔第三大市場。該設備可提供長期心率監測，並與公司更廣泛的心律管理產品組合整合。儘管波士頓科學公司保持穩定的市場地位，但其市場佔有率仍落後於主要企業。

競爭格局主要集中在少數幾家擁有成熟客戶關係管理（CRM）產品組合的主要企業之間。競爭的促進因素包括診斷準確性的提高、設備小型化以及遠端監控能力的增強。

技術和臨床趨勢

人工智慧 (AI) 是影響植入式心臟監測器市場的最重要趨勢。 AI 演算法能夠提高偵測準確率並減少誤報，從而提高設備可靠性並促進臨床應用。

小型化技術不斷提升患者體驗和治療效率。較小的醫療器材更容易植入，創傷更小，因此應用範圍更廣。

遠端監測也是一個重要的發展趨勢。現代設備可自動將資料傳輸到雲端平台，從而實現對患者的持續監測，並減少患者到院進行追蹤的需要。

與更廣泛的數位醫療系統的整合正在取得進展。植入式監測器正成為互聯醫療生態系統的一部分，從而支持對心血管疾病患者進行更全面的管理。

地區

本報告涵蓋全球調查區域，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

本報告包含一份詳細的 46 頁市場分析、市場區隔和預測。

調查方法附錄和簡稱詞彙表。

這份報告的意義

哪些因素推動了全球植入式心臟監測器市場的成長？

人工智慧如何提高診斷的準確性和普及程度？

人口趨勢在擴大患者群體中扮演什麼角色？

哪些公司在市場中處於領先地位？它們的競爭力如何？

成本和還款的挑戰如何影響區域推廣？

到 2032 年有哪些成長機會？

iData Research 的「全球植入式心臟監測器市場報告」透過詳盡的數據和分析解答了這些問題。利用這份報告，您可以了解市場需求、與競爭對手進行比較，並在蓬勃發展的心臟監測領域制定策略。

目錄

圖表清單

調查方法

• 步驟 1：計劃啟動與團隊組建
• 步驟 2：準備資料系統並進行二次調查。
• 步驟 3：設計和準備訪談和調查問卷。
• 步驟 4：進行初步調查
• 步驟 5：調查與分析：建立基準估計值
• 步驟 6：市場預測與分析
• 步驟 7：辨識策略機遇
• 步驟 8：最終審核和市場推廣
• 步驟 9：客戶回饋與市場監測

全球關稅的影響

植入式心臟監測器市場

• 全球植入式心臟監測器市場概覽
• 競爭分析
• 目標區域

介紹

手術次數

市場分析與預測

促進因素和抑制因素

競爭性市佔率分析

簡稱

Global Insertable Cardiac Monitor Market Report

The global insertable cardiac monitor market was valued at over $1.32 billion in 2025 and is expected to grow at a CAGR of 4.6% to reach nearly $1.81 billion by 2032. Growth is supported by increasing demand for long-term cardiac rhythm monitoring and earlier detection of arrhythmias.

This report follows the same structure and methodology as the provided example, adapted to the insertable cardiac monitor market and its specific clinical use cases . It includes detailed analysis of unit sales, average selling prices, procedural volumes and competitive positioning across global regions.

Cardiovascular disease continues to rise globally, driven by aging populations and increasing prevalence of obesity, diabetes and other metabolic risk factors. The global population over 60 has surpassed 1.2 billion and is expected to approach 1.5 billion by the early 2030s, expanding the patient base for arrhythmia monitoring.

A key driver of market growth is the integration of artificial intelligence into insertable cardiac monitors. Technologies such as Medtronic's AccuRhythm and Abbott's Assert-IQ improve diagnostic accuracy by reducing false positives while maintaining sensitivity to clinically significant events, increasing physician confidence and supporting broader adoption.

Market Overview

The global insertable cardiac monitor market consists of implantable devices designed for continuous, long-term monitoring of cardiac rhythm. These devices are typically used in patients with infrequent or unexplained arrhythmias, where traditional external monitoring methods are insufficient.

Insertable cardiac monitors play a critical role in diagnosing conditions such as atrial fibrillation, syncope and cryptogenic stroke. Their ability to provide continuous monitoring over extended periods allows clinicians to capture intermittent events that would otherwise go undetected.

The market is closely tied to trends in cardiovascular disease. As the prevalence of arrhythmias increases with age and comorbid conditions, demand for long-term monitoring solutions continues to grow. Insertable monitors are increasingly used as part of standard diagnostic pathways, particularly in patients at risk of stroke or sudden cardiac events.

Technological advancements are reshaping the market. Devices are becoming smaller, easier to implant and more integrated with remote monitoring platforms. The addition of AI-driven algorithms is improving diagnostic accuracy and reducing clinician workload, positioning insertable cardiac monitors as a key tool in modern cardiac care.

Market Drivers

The insertable cardiac monitor market is driven by the need to reduce mortality associated with cardiovascular disease. With cardiovascular disease remaining the leading cause of death globally, there is strong clinical incentive to detect arrhythmias earlier and initiate appropriate treatment. Insertable monitors provide a reliable method for identifying clinically significant events in high-risk patients.

Advances in arrhythmia detection and treatment are also supporting market growth. As therapies for complex arrhythmias improve, the value of accurate diagnosis increases. Insertable monitors enable detection of infrequent or asymptomatic arrhythmias, which would otherwise remain undiagnosed, leading to increased utilization of these devices.

Artificial intelligence represents the most significant technological driver. AI-enabled detection algorithms reduce false positive alerts while maintaining high sensitivity. This improves workflow efficiency and increases physician confidence in device data, supporting broader adoption across clinical settings.

Market Limiters

The primary limitation of the insertable cardiac monitor market is the high cost of implantation procedures. In 2025, the total cost of an implantation procedure typically ranged from $10,000 to $15,000. This places the procedure outside the budget of many patients, even in developed markets with insurance coverage.

Cost constraints also impact adoption in emerging markets, where reimbursement systems may not fully support the use of insertable monitors. As a result, utilization remains concentrated in higher-income regions and specialized care centers.

Another limitation is the need for clear clinical justification. While insertable monitors provide valuable diagnostic data, their use must be balanced against cost considerations. In some cases, physicians may opt for less expensive external monitoring methods before proceeding to implantation.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, competitive analysis, mergers and acquisitions, company profiles and product portfolios.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

Markets Covered and Segmentation

The report covers the Global Insertable Cardiac Monitor Market.

The market is analyzed as a unified segment, reflecting the standardized nature of insertable cardiac monitor technology across clinical applications.

All data is segmented by unit volume, average selling price and market value, with forecasts through 2032.

Competitive Analysis

Medtronic leads the global insertable cardiac monitor market in 2025, supported by its LINQ II and Reveal LINQ systems. The LINQ II platform incorporates advanced AI-driven arrhythmia detection and enhanced remote monitoring capabilities, strengthening Medtronic's position as the market leader. The Reveal LINQ remains widely used for long-term monitoring due to its minimally invasive design and established clinical performance.

Abbott holds the second-leading position with a portfolio that includes Confirm Rx, Jot Dx and Assert-IQ devices. These systems offer mobile-enabled data transmission and streamlined remote monitoring, supporting efficient patient management. Abbott's integration of AI-based detection algorithms has improved diagnostic accuracy and strengthened its competitive position.

Boston Scientific ranks third in the market with its LUX-Dx insertable cardiac monitor. The device provides long-term rhythm monitoring and integrates with the company's broader cardiac rhythm management portfolio. While Boston Scientific maintains a stable position, its market share remains behind the leading competitors.

The competitive landscape is concentrated among a small number of major players with established CRM portfolios. Competition is driven by improvements in diagnostic accuracy, device miniaturization and remote monitoring capabilities.

Technology and Practice Trends

Artificial intelligence is the most important trend shaping the insertable cardiac monitor market. AI-driven algorithms improve detection accuracy and reduce false positive alerts, making devices more reliable and easier to use in clinical practice.

Miniaturization continues to improve patient experience and procedural efficiency. Smaller devices are easier to implant and less invasive, supporting wider adoption.

Remote monitoring is also a key trend. Modern devices transmit data automatically to cloud-based platforms, enabling continuous patient monitoring and reducing the need for in-person follow-up visits.

Integration with broader digital health systems is increasing. Insertable monitors are becoming part of connected care ecosystems, supporting more comprehensive management of cardiovascular patients.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

46 pages of detailed market analysis, segmentation and forecasts.

Methodology Appendix and Acronym Glossary.

Why This Report

What is driving growth in the global insertable cardiac monitor market?

How is artificial intelligence improving diagnostic accuracy and adoption?

What role do demographic trends play in expanding the patient base?

Which companies lead the market and how strong are their competitive positions?

How do cost and reimbursement challenges impact adoption across regions?

What are the key opportunities for growth through 2032?

The Global Insertable Cardiac Monitor Market Report from iData Research answers these questions with detailed data and analysis. Use it to understand demand, benchmark competitors and plan strategy in a growing segment of cardiac monitoring.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Insertable Cardiac Monitor Market

• 8.1.1 Global Insertable Cardiac Monitor Market Overview
• 8.1.2 Competitive Analysis
• 8.1.3 Regions Included

Introduction

Procedure Numbers

Market Analysis And Forecast

Drivers And Limiters

• 8.1.4 Market Drivers
• 8.1.5 Market Limiters

Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Chart 8-2: Insertable Cardiac Monitor Placement Procedures, Global, 2025
• Chart 8-3: Insertable Cardiac Monitor Placement Procedures by Region, Global, 2022 - 2032
• Chart 8-4: Insertable Cardiac Monitor Device Market, Global, 2022 - 2032
• Chart 8-5: Leading Competitors, Insertable Cardiac Monitor Market, Global, 2025

LIST OF FIGURES

• Figure 8-1: Insertable Cardiac Monitor Regions Covered, Global (1 of 2)
• Figure 8-2: Insertable Cardiac Monitor Regions Covered, Global (2 of 2)
• Figure 8-3: Insertable Cardiac Monitor Placement Procedures by Region, Global, 2022 - 2032
• Figure 8-4: Insertable Cardiac Monitor Placement Procedures by Country, North America, 2022 - 2032
• Figure 8-5: Insertable Cardiac Monitor Placement Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-6: Insertable Cardiac Monitor Placement Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-7: Insertable Cardiac Monitor Placement Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-8: Insertable Cardiac Monitor Placement Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-9: Insertable Cardiac Monitor Placement Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-10: Insertable Cardiac Monitor Placement Procedures by Country, Middle East, 2022 - 2032
• Figure 8-11: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-12: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-13: Insertable Cardiac Monitor Placement Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-14: Insertable Cardiac Monitor Placement Procedures by Country, Africa, 2022 - 2032
• Figure 8-15: Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Figure 8-16: Units Sold by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032
• Figure 8-17: Average Selling Price by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032 (US$)
• Figure 8-18: Market Value by Region, Insertable Cardiac Monitor Market, Global, 2022 - 2032 (US$M)
• Figure 8-19: Leading Competitors, Insertable Cardiac Monitor Market, Global, 2025